(Q37774916)

23 August 2017

1 reference

title

Prognostic factors in pediatric acute myeloid leukemia (English)

1 reference

23 August 2017

1 reference

Mohamed Radhi

1

1 reference

PubMed ID

20652454

23 August 2017

Soheil Meshinchi

series ordinal

2

1 reference

PubMed ID

20652454

23 August 2017

Alan Gamis

series ordinal

3

1 reference

23 August 2017

1 October 2010

1 reference

Current hematologic malignancy reports

23 August 2017

1 reference

23 August 2017

5

1 reference

23 August 2017

4

1 reference

23 August 2017

200-206

1 reference

https://scigraph.springernature.com/pub.10.1007/s11899-010-0060-z

23 August 2017

0 references

cites work

Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group

1 reference

12 December 2020

Prognostic factors in acute myeloid leukemia

1 reference

12 December 2020

Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study

1 reference

12 December 2020

Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: a study of the German-Austrian AML Study Group

1 reference

12 December 2020

Prognostic relevance of FLT3-TKD mutations in AML: the combination matters--an analysis of 3082 patients

1 reference

12 December 2020

Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study

1 reference

12 December 2020

Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party

1 reference

12 December 2020

MRC trials in childhood acute myeloid leukaemia

1 reference

12 December 2020

Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study

1 reference

12 December 2020

Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia

1 reference

12 December 2020

Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?

1 reference

12 December 2020

Molecular characterization of AML: a significant advance or just another prognostic factor?

1 reference

12 December 2020

Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group

1 reference

12 December 2020

Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study

1 reference

12 December 2020

KIT mutations, and not FLT3 internal tandem duplication, are strongly associated with a poor prognosis in pediatric acute myeloid leukemia with t(8;21): a study of the Japanese Childhood AML Cooperative Study Group

1 reference

12 December 2020

Improved treatment results in childhood acute myelogenous leukemia: a report of the German cooperative study AML-BFM-78

1 reference

12 December 2020

Absolute lymphocyte count is a novel prognostic indicator in ALL and AML: implications for risk stratification and future studies

1 reference

12 December 2020

Clinical implications of FLT3 mutations in pediatric AML.

1 reference

12 December 2020

Clinical significance of residual disease during treatment in childhood acute myeloid leukaemia

1 reference

12 December 2020

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

1 reference

12 December 2020

Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia

1 reference

12 December 2020

1 reference

12 December 2020

Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study

1 reference

12 December 2020

Independent prognostic factors for AML outcome

1 reference

12 December 2020

Pediatric acute myeloid leukemia: towards high-quality cure of all patients

1 reference

12 December 2020

Effect of race on outcome of white and black children with acute myeloid leukemia: the St. Jude experience.

1 reference

12 December 2020

Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.

1 reference

12 December 2020

Residual disease monitoring in childhood acute myeloid leukemia by multiparameter flow cytometry: the MRD-AML-BFM Study Group.

1 reference

12 December 2020

Early peripheral blood blast clearance during induction chemotherapy for acute myeloid leukemia predicts superior relapse-free survival

1 reference

12 December 2020

Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891.

1 reference

12 December 2020

Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML.

1 reference

12 December 2020

Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia.

1 reference

12 December 2020

Acute myeloid leukemia

1 reference

12 December 2020

WT1 expression at diagnosis does not predict survival in pediatric AML: a report from the Children's Oncology Group

1 reference

12 December 2020

Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia

1 reference

12 December 2020

CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations

1 reference

12 December 2020

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

1 reference

12 December 2020

Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype

1 reference

12 December 2020

Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML

1 reference

12 December 2020

Mortality in overweight and underweight children with acute myeloid leukemia

1 reference

12 December 2020

Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213.

1 reference

12 December 2020

Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia

1 reference

12 December 2020

Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821

1 reference

12 December 2020

Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group

1 reference

12 December 2020

Prognostic factors in AML in relation to (ab)normal karyotype

1 reference

12 December 2020

Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy.

1 reference

12 December 2020

10.1007/S11899-010-0060-Z

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

20652454